Total Payments
$2,562
2022 Payments
$466.46
Companies
24
Transactions
128
Medicare Patients
689
Medicare Billing
$118,427
Payment Breakdown by Category
Food & Beverage$2,219 (86.6%)
Education$320.40 (12.5%)
Other$22.92 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,219 | 117 | 86.6% |
| Education | $320.40 | 10 | 12.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22.92 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $419.58 | 24 | $0 (2022) |
| Astellas Pharma US Inc | $387.41 | 11 | $0 (2019) |
| Paratek Pharmaceuticals, Inc. | $202.53 | 10 | $0 (2022) |
| ViiV Healthcare Company | $184.67 | 9 | $0 (2022) |
| Gilead Sciences, Inc. | $160.81 | 8 | $0 (2022) |
| Allergan, Inc. | $155.52 | 11 | $0 (2020) |
| ABBVIE INC. | $150.02 | 8 | $0 (2022) |
| Insmed, Inc. | $150.01 | 6 | $0 (2022) |
| Shionogi Inc | $134.10 | 6 | $0 (2022) |
| Theravance Biopharma, Inc. | $103.63 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $466.46 | 23 | Shionogi Inc ($115.61) |
| 2021 | $199.95 | 11 | AbbVie Inc. ($74.98) |
| 2020 | $286.89 | 16 | Merck Sharp & Dohme Corporation ($123.25) |
| 2019 | $642.88 | 29 | Astellas Pharma US Inc ($200.57) |
| 2018 | $272.43 | 16 | EMD Serono, Inc. ($62.22) |
| 2017 | $693.49 | 33 | Astellas Pharma US Inc ($156.85) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/28/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: ANTIBIOTIC | ||||||
| 11/22/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Respiratory | ||||||
| 11/17/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/28/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/13/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.69 | General |
| 10/06/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/29/2022 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: HIV | ||||||
| 09/22/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/19/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: ANTIBIOTIC | ||||||
| 09/09/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: ANTIBIOTIC | ||||||
| 09/01/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/11/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/08/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: ANTIBIOTIC | ||||||
| 05/20/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/19/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/25/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Rare Disease | ||||||
| 04/14/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: ANTIBIOTIC | ||||||
| 04/12/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/08/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/16/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Infections and Infectious Diseases | ||||||
| 01/12/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Immunology | ||||||
| 01/05/2022 | Amgen Inc. | Tavneos (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Not Applicable | ||||||
| 12/21/2021 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: ANTIBIOTIC | ||||||
| 12/20/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 169 | 402 | $344,462 | $36,088 |
| 2021 | 3 | 228 | 464 | $121,210 | $42,233 |
| 2020 | 4 | 292 | 463 | $93,484 | $40,105 |
Total Patients
689
Total Services
1,329
Medicare Billing
$118,427
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 76 | 252 | $197,796 | $20,928 | 10.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 63 | $102,545 | $10,118 | 9.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 87 | $44,121 | $5,042 | 11.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 96 | 263 | $57,552 | $22,120 | 38.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 69 | 82 | $44,150 | $13,159 | 29.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 63 | 119 | $19,508 | $6,954 | 35.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 111 | 213 | $40,140 | $17,675 | 44.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 68 | 72 | $26,495 | $11,329 | 42.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 101 | 156 | $21,945 | $9,051 | 41.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 22 | $4,904 | $2,051 | 41.8% |
About Dr. Sushma Singh, MBBS
Dr. Sushma Singh, MBBS is a Infectious Disease healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1245493360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sushma Singh, MBBS has received a total of $2,562 in payments from pharmaceutical and medical device companies, with $466.46 received in 2022. These payments were reported across 128 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,219).
As a Medicare-enrolled provider, Singh has provided services to 689 Medicare beneficiaries, totaling 1,329 services with total Medicare billing of $118,427. Data is available for 3 years (2020–2022), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Sugar Land, TX
- Active Since 07/09/2008
- Last Updated 09/17/2025
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1245493360
Products in Payments
- NUZYRA (Drug) $202.53
- AVYCAZ (Drug) $172.49
- Arikayce (Drug) $150.01
- Fetroja (Drug) $134.10
- VIBATIV (Drug) $103.63
- inCourage (Device) $101.91
- ZERBAXA (Drug) $96.60
- DALVANCE (Drug) $96.01
- TRIUMEQ (Drug) $83.18
- BELSOMRA (Drug) $79.77
- DIFICID (Drug) $73.42
- ISENTRESS (Drug) $70.43
- NOXAFIL (Drug) $64.81
- Gonal-f (Biological) $62.22
- ENTRESTO (Drug) $60.95
- EGRIFTA (Drug) $58.00
- Cresemba (Drug) $57.85
- JULUCA (Drug) $44.57
- CRESEMBA (Drug) $41.59
- TEFLARO (Drug) $37.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Sugar Land
Irene Ekaney, Md, MD
Infectious Disease — Payments: $21,310
Infectious Disease $21,310
John Butler, Md, MD
Infectious Disease — Payments: $19,539
Infectious Disease $19,539
Obiageli Obijiofor, Md, MD
Infectious Disease — Payments: $10,941
Infectious Disease $10,941
Farheen Tariq, M.d, M.D
Infectious Disease — Payments: $599.16
Infectious Disease $599.16
Ambreen Allana, Md, MD
Infectious Disease — Payments: $460.87
Infectious Disease $460.87
Anh Nguyen, Md, MD
Infectious Disease — Payments: $209.02
Infectious Disease $209.02